Browsing Tag
NFL-101
2 posts
NFL Biosciences secures €1.2m non-dilutive funding to accelerate Phase 3 development of NFL-101
Find out how NFL Biosciences secured €1.2 million non-dilutive funding to accelerate Phase 3 of NFL-101, a first-in-class botanical smoking cessation drug.
July 22, 2025
Themis Medicare, NFL Biosciences partner on smoking cessation candidate NFL-101
Indian pharmaceutical company Themis Medicare has joined hands with French biotech company NFL Biosciences to develop NFL-101, a…
October 10, 2022